NCT04556890View on ClinicalTrials.gov

Pain and Major Depressive Disorder

NARecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

October 31, 2027

Conditions
Major Depressive DisorderChronic Pain
Interventions
DEVICE

Active rTMS/Active iTBS DFPLC/Sham Pain M1

Active rTMS treatment for depression (600 pulses of active intermittent theta burst (iTBS) administrated at 120% MT to the left DLPFC) and sham treatment for pain at M1

DEVICE

Active rTMS/Active iTBS

Active rTMS treatment for both, depression and pain (600 pulses of iTBS to left DLPFC followed by 600 iTBS + 1500 pulses of 10 Hz to M1

Trial Locations (1)

90024

RECRUITING

UCLA Semel Institute, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER